Clinical Trial Update: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of HTD1801, a berberine-ursodeoxycholate formulation, in adults with Type 2 Diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HTD1801 (Berberine Ursodeoxycholate) (Berberine Ursodeoxycholate)

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED